Content about Nepafenac

January 21, 2013

Eye care company Alcon has launched a treatment for pain and inflammation resulting from cataract surgery, the company said Monday.

NEW YORK — Eye care company Alcon has launched a treatment for pain and inflammation resulting from cataract surgery, the company said Monday.

The company said Ilevro (nepafenac) ophthalmic suspension was a nonsteroidal anti-inflammatory drug and once-daily treatment for cataract surgery patients.

October 17, 2010

Ista Pharmaceuticals has won approval from the Food and Drug Administration for a drug used...

IRVINE, Calif. Ista Pharmaceuticals has won approval from the Food and Drug Administration for a drug used to treat eye surgery patients.

 

The drug maker announced the approval of Bromday (bromfenac) ophthalmic solution as a once-daily eye drop for treating pain and inflammation in patients who have received cataract extraction surgery. The drug is a nonsteroidal anti-inflammatory drug, or NSAID, belonging to the same class as the common painkiller ibuprofen. The company plans to launch the drug at the end of this year.